Member Info for Buildworker

Show me the money!

News broke late in the day, so hoping for further gains tomorrow. What a pleasant surprise when I logged back on!

Had to look up LTIP, doh! “A long-term incentive plan (LTIP) is a company policy that rewards employees for reaching specific goals that lead to increased shareholder value. “

So I’m hoping, no praying that this RNS is a precursor to some very positive news to come in the near future. Boy do we need some shareholder value.

Quick search for latest FUM news and it’s only Proactive picking this up. There in lies the problem, poor media relations.

Combined US and Mexico launch perhaps? US manufacturing partner? US listing?

So many possibilities and such huge potential, this has got to fly soon.

Q3 trading update would be nice, unless they don’t want us to know what’s occurring!

Wow James, don’t dress it up!

During the interim results presentation COO Angela Hildreth stated the will be at least 10 new country launches in the next 6 months. By my reckoning we’re due some good news very soon!

Also noticed on the product innovation slide, a pump action dispenser - that’s something to get excited about. The Futura is getting brighter!

25% wiped off. Does somebody know something we don’t ?

It’s a mystery to me. Buys outnumbering sells, but SP still falling, even with all the good news on the horizon. Fum need a decent PR company imo.

Finished blue, what a relief!

“With further commercial agreements and product launches planned through the remainder of 2023 and beyond, Futura is well positioned to continue on its growth trajectory, bringing a new OTC ED breakthrough treatment to sufferers globally”.

Bring it on, let’s have some news!

I note Cooper have finally updated their media page to include a press release on Eroxon. Still no links from Eroxon.com to online shopping sites for the rest of Europe, so I feel they could be doin a lot more to promote the product. No links to Germany for example.

Tend to agree with you Bucolic, or at least a fair chunk. This is my single biggest investment as I was so convinced it would fly with US approval. It’s dragging the value of my portfolio down and I need to diversify.

It’s of little comfort I know, but everything on my board, bar one is red today. Hoping for a strong finish to the week, or I may have to go and get a proper job again.

Just a thought, but Haleon with a market capitalisation of £31 billion, were prepared to pay £4 million up front for distribution rights and so on, so must have a high degree of confidence in the potential for Eroxon in the US. Why didn’t they just buy the company, or am I just being naive?

I also note BE in 24 is based on sales generated, excluding US. Why no US forecast included?

Thanks Beech, good post. Let’s hope the analysts agree with you.

Just watched the interview and Barder is certainly upbeat. Now understand what he means by 20% incremental increase, I.e. Eroxon is not taking market share from other ED treatments, but rather expanding the overall market. Forward projections don’t even take into account US sales, futura looks bright. It’s a waiting game.

We need a whale, let’s hope it’s a blue one!